Evaluating pharmacokinetic/pharmacodynamic models using the posterior predictive check
Y Yano, SL Beal, LB Sheiner - Journal of pharmacokinetics and …, 2001 - Springer
The posterior predictive check (PPC) is a model evaluation tool. It assigns a value (p PPC) to
the probability that the value of a given statistic computed from data arising under an …
the probability that the value of a given statistic computed from data arising under an …
Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models
JD Unadkat, F Bartha… - Clinical Pharmacology & …, 1986 - Wiley Online Library
Three models, linked in series, can be used to analyze combined pharmacokinetic (PK) and
pharmacodynamic (PD) data arising from non—steady‐state experiments. A PK model …
pharmacodynamic (PD) data arising from non—steady‐state experiments. A PK model …
Evaluation of different tests based on observations for external model evaluation of population analyses
To evaluate by simulation the statistical properties of normalized prediction distribution
errors (NPDE), prediction discrepancies (pd), standardized prediction errors (SPE) …
errors (NPDE), prediction discrepancies (pd), standardized prediction errors (SPE) …
Extensions to the visual predictive check to facilitate model performance evaluation
Abstract The Visual Predictive Check (VPC) is a valuable and supportive instrument for
evaluating model performance. However in its most commonly applied form, the method …
evaluating model performance. However in its most commonly applied form, the method …
Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model
E Fuseau, LB Sheiner - Clinical Pharmacology & Therapeutics, 1984 - Wiley Online Library
We describe a variation on an approach to simultaneous modeling of pharmacokinetics (PK)
and pharmacodynamics (PD). Both approaches model the often‐observed time lag between …
and pharmacodynamics (PD). Both approaches model the often‐observed time lag between …
Use of prior information to stabilize a population data analysis
PO Gisleskog, MO Karlsson, SL Beal - Journal of pharmacokinetics and …, 2002 - Springer
When modeling new data with a complex population pharmacokinetic/pharmacodynamic
model, there may not be sufficient information to obtain estimates of all parameters. In this …
model, there may not be sufficient information to obtain estimates of all parameters. In this …
[PDF][PDF] Do you need a pharmacokinetic model, and, if so, which one?
JG Wagner - 1975 - deepblue.lib.umich.edu
My theses are (a) most of the time we cannot determine which specific model applies to one
or more sets of data, but only which class of model applies;(b) when linear pharmacokinetics …
or more sets of data, but only which class of model applies;(b) when linear pharmacokinetics …
Standardized visual predictive check versus visual predictive check for model evaluation
DD Wang, S Zhang - The Journal of Clinical Pharmacology, 2012 - Wiley Online Library
The visual predictive check (VPC) is a commonly used approach in model evaluation.
However, it may not be feasible to conduct a VPC, or the results of a VPC could be …
However, it may not be feasible to conduct a VPC, or the results of a VPC could be …
Simultaneous vs. sequential analysis for population PK/PD data I: best-case performance
L Zhang, SL Beal, LB Sheiner - Journal of pharmacokinetics and …, 2003 - Springer
Abstract Dose [-concentration]-effect relationships can be obtained by fitting a predictive
pharmacokinetic (PK)-pharmacodynamic (PD) model to both concentration and effect …
pharmacokinetic (PK)-pharmacodynamic (PD) model to both concentration and effect …
Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects
JW Mandema, D Verotta, LB Sheiner - Journal of pharmacokinetics and …, 1992 - Springer
One major task in clinical pharmacology is to determine the pharmacokinetic-
pharmacodynamic (PK-PD) parameters of a drug in a patient population. NONMEM is a …
pharmacodynamic (PK-PD) parameters of a drug in a patient population. NONMEM is a …